By Jacob Bell Published August 7, 2026 In a signal that the biotechnology sector has finally shaken...
Chemotherapy and Targeted Therapy
Fifty-five years after the Controlled Substances Act of 1970 relegated psilocybin to Schedule I status—placing it alongside...
In the era of “big data” in healthcare, clinicians are frequently confronted with a modern paradox: they...
From Biotech Startup to $800 Million Acquisition: The Remarkable Evolution of Alkeus Pharmaceuticals
From Biotech Startup to $800 Million Acquisition: The Remarkable Evolution of Alkeus Pharmaceuticals
In a landmark deal that underscores the high-stakes world of rare disease drug development, Tarsus Pharmaceuticals has...
By BioPharma Investigative Desk August 6, 2026 In a move that marks a pivotal, if precarious, turning...
As the pharmaceutical industry navigates an era defined by rapid digital transformation and the increasing complexity of...
For over a decade, the American Society of Clinical Oncology’s (ASCO) CancerLinQ platform stood as a noble,...
In a definitive escalation of the pharmaceutical industry’s race toward computational drug discovery, Bristol Myers Squibb (BMS)...
In the rapidly evolving landscape of modern pharmacology, the narrative has been dominated by the meteoric rise...
The global pharmaceutical landscape is currently defined by a high-stakes, multi-billion-dollar race to dominate the obesity medication...
